Key takeaways
- GLP-1 medications like Ozempic and Mounjaro are reshaping not just what people eat, but how they relate to eating itself — from appetite and cravings to social meals and emotional connection with food.
- Behavioural shifts go beyond smaller baskets and fewer snacks. They extend into identity, confidence, social dynamics, and self-perception.
- Quantitative data shows the what — shifts in category purchases, healthier food choices. Qualitative research reveals the why behind those shifts, the emotions and identity changes driving them.
- For brands in food, beverage, wellness, retail, and healthcare, understanding GLP-1 consumer insights means adapting to a consumer whose values and motivations are visibly changing.
- With Indeemo, brands can capture these shifts in context — through mobile ethnography and diary-based research that follows participants' real lives over time.
A new era of appetite, identity, and consumption
A quiet but profound shift is underway in how people think about food, health, and themselves, driven by GLP-1 medications like Ozempic and Mounjaro. What began as a medical intervention for weight management has evolved into a cultural turning point, reshaping not only what people eat but how they relate to eating itself.
For many, these treatments bring relief, balance, and a renewed sense of control. Yet the impact runs deeper than appetite. As hunger softens and cravings fade, people often describe an unfamiliar distance from food — a feeling of calm detachment that can be both liberating and unsettling. Shared meals lose their centrality. Emotional connections between nourishment, comfort, and reward begin to reconfigure.
These personal transformations ripple outward into daily life, influencing how people shop, exercise, and socialise, and altering self-perception, confidence, and even professional identity. GLP-1 consumer insights reveal not only new habits, but an entirely new way of thinking about self and satisfaction.
Why do GLP-1 consumer insights matter?
At first glance, the impact of GLP-1 seems purely behavioural. Smaller baskets, fewer snacks, more functional food choices. But these data points only tell part of the story.
What's missing is why. Why do people feel calmer yet more detached from food? Why does social dining feel different? Why does confidence increase for some, while others feel disoriented by change?
That's the value of GLP-1 consumer insights. They uncover the human story behind shifting behaviours, revealing the emotions, identity shifts, and lived experiences driving the numbers. Understanding those motivations gives brands, researchers, and retailers the context they need to adapt meaningfully.
What does GLP-1 behavioural change look like in context?
The behavioural effects of GLP-1 extend far beyond appetite suppression. Food becomes more functional than emotional. Impulse categories such as snacks, desserts, and alcohol decline, while interest in hydration, supplements, and fitness grows.
But this isn't simply about consumption. It's about values. Control, balance, and wellbeing are replacing indulgence as guiding principles of modern living. For some, this means freedom. For others, a loss of pleasure or spontaneity.
This is what makes GLP-1 consumer insights so valuable. They capture nuance. They show how the same medication can trigger empowerment in one person and emotional disconnection in another. These lived experiences explain not just what is changing, but how it feels to change.
How does Indeemo capture GLP-1 consumer insights?
Understanding transformation requires more than interviews or surveys. It demands observation in context, over time, and through the participant's own eyes. Indeemo enables exactly this.
Using mobile ethnography and diary-based research, participants share reflections from their real lives — at home, in shops, at the table, or on a walk. Over days and weeks, these moments form a living narrative of transformation.
This approach turns research into empathy. Instead of extracting answers, Indeemo helps participants tell stories. Those stories — authentic, emotional, and grounded in context — illuminate the human side of GLP-1 behavioural change in a way no dashboard can.
Alongside GLP-1 research, Indeemo supports the end-to-end qualitative workflow:
- Recruit B2C participants in hours from a panel of 3 million+ respondents
- Capture in-the-moment videos, photos, screen recordings, and texts in 30+ languages
- Use generative AI for summarisation, translation, thematic analysis, and sentiment analysis to speed up analysis significantly
- Import follow-up interviews from Zoom or Microsoft Teams to probe deeper on themes that emerge from diary data
- Create subtitled highlight reels to share participant voice with product, marketing, healthcare, or investor audiences
What do GLP-1 consumer insights mean for brands and retailers?
GLP-1 medications signal more than a health trend. They represent a deep shift in identity, motivation, and value systems. For organisations trying to stay relevant, the opportunity lies in empathy-led understanding.
- Food, beverage, and wellness brands can design communication and products that align with new consumer values of moderation, function, and self-control.
- Retailers can anticipate smaller, more purposeful baskets and new shopping missions centred on wellbeing.
- Healthcare and wellness professionals can better support people through both the emotional and physical aspects of transformation.
By grounding decisions in GLP-1 consumer insights, organisations can move from reactive strategy to meaningful understanding — meeting consumers where they truly are.
The Indeemo perspective
At Indeemo, we believe the most meaningful insights come from lived experience. Behavioural change is never linear. It's layered with emotion, identity, and context.
GLP-1 is reshaping all of these at once. To really grasp its impact, we need to go beyond data and into the human experience behind it. Indeemo helps researchers and brands see that world — in context, over time, and through the participant's own lens.
While basket analysis shows the what, Indeemo reveals the why — bringing you closer to how GLP-1 users are really living, eating, and feeling.
Do you need to be a healthcare researcher to run this kind of study?
No. Whether you're a consumer brand, a retailer, a healthcare team, or an agency running work for a client, Indeemo can support you.
Use the platform independently, or partner with our Catalyst team for study design, recruitment, moderation, and analysis. If you have research ambitions but not the capacity to run the project yourself, we can lend a helping hand.
Frequently asked questions
What are GLP-1 medications? GLP-1 receptor agonists — including brands like Ozempic, Wegovy, and Mounjaro — are medications originally developed for type 2 diabetes and increasingly prescribed for weight management. They work by regulating appetite, blood sugar, and satiety.
Why is qualitative research better suited to GLP-1 insights than surveys? Surveys capture stated preferences and self-reported behaviour. GLP-1 changes are emotional and contextual — they show up in meal moments, shopping baskets, social situations, and shifts in self-perception. Qualitative research in context captures the lived experience that surveys miss.
What kinds of brands should be paying attention to GLP-1 consumer insights? Food and beverage, wellness and supplements, retail and grocery, fitness, hospitality, fashion, and healthcare. Any category that connects to eating, consumption, identity, or daily ritual is being reshaped by GLP-1 usage among its customers.
How long should a GLP-1 behavioural research study run? Most studies benefit from running over several weeks so participants can capture the full range of moments — meals, social occasions, shopping trips, and quiet reflections. Diary-based mobile ethnography works well for this kind of longitudinal insight.
Is it appropriate to study participants taking GLP-1 medications? Yes, with proper ethical consideration. Research on lived experience with medication is standard in healthcare and consumer insights work, provided studies are designed around informed consent, participant wellbeing, and clear boundaries around what the research does and does not claim.
